-
Symbol
-
SABS on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
25.9M shares
-
Security Ownership
-
9.99%
Vivo Opportunity Fund Holdings, L.P. ownership in SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (SABS)
2025-10-03 - Vivo Opportunity Fund Holdings, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 25.9M shares of SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (SABS).
This represents 9.99% percent ownership of the company.